Critical illness-associated diaphragm weakness.
Martin Dres, Ewan C Goligher, Leo M A Heunks...
https://pubmed.ncbi.nlm.nih.gov/28917004Actively Recruiting
Led by KU Leuven · Updated on 2026-03-18
90
Participants Needed
1
Research Sites
N/A
Total Duration
Mechanical ventilation is a critical treatment used in intensive care units but can cause weakness and loss of muscle in the respiratory muscles. This weakness is linked to longer ventilation times, difficulty in stopping ventilation, and higher mortality in the ICU. Researchers are studying how respiratory muscle training affects muscle function in patients who have trouble weaning off mechanical ventilation, aiming to better understand the physiological changes in response to different training methods. The study compares three approaches during the weaning period: usual care with intermittent spontaneous breathing, usual care plus high-intensity inspiratory muscle training (IMT) using a tapered flow resistive device, and usual care plus low-intensity (sham) IMT. The high-intensity training involves supervised daily sessions with increasing resistance to improve breathing muscle strength, while the low-intensity group uses minimal resistance as a control. The study will investigate which training method provides better respiratory muscle conditioning. Participants will be monitored for up to 28 days during the training period. Researchers will assess maximal inspiratory pressure and use ultrasound to measure diaphragm movement and thickness. They will also analyze muscle tissue changes, blood flow, oxygen levels, and electrical activity of respiratory muscles. These assessments will help measure muscle strength, structure, and function. The study aims to optimize muscle training to aid patients in successfully stopping mechanical ventilation.
CONDITIONS
Improving Our Understanding of Respiratory Muscle Training to Facilitate Weaning From Mechanical Ventilation in the ICU
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 28 days
Participants receive usual care with intermittent spontaneous breathing periods and are randomly assigned to either high-intensity or low-intensity inspiratory muscle training using a tapered flow resistive device.
Daily supervised training sessions
Total: 1 location
1
University Hospital Leuven
Leuven, Belgium, 3000
Actively Recruiting
D
Daniel Langer, PT, PhD
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Martin Dres, Ewan C Goligher, Leo M A Heunks...
https://pubmed.ncbi.nlm.nih.gov/28917004Stefannie Vorona, Umberto Sabatini, Sulaiman Al-Maqbali...
https://pubmed.ncbi.nlm.nih.gov/29584447Gerald S Supinski, Leigh Ann Callahan
https://pubmed.ncbi.nlm.nih.gov/23786764Martin Dres, Ewan C Goligher, Bruno-Pierre Dubé...
https://pubmed.ncbi.nlm.nih.gov/29687276Mark Elkins, Ruth Dentice
https://pubmed.ncbi.nlm.nih.gov/26092389Daniel Langer, Noppawan Charususin, Cristina Jácome...
https://pubmed.ncbi.nlm.nih.gov/25858974Mariana Hoffman, Marine Van Hollebeke, Beatrix Clerckx...
https://pubmed.ncbi.nlm.nih.gov/29961023Pierantonio Laveneziana, Andre Albuquerque, Andrea Aliverti...
https://pubmed.ncbi.nlm.nih.gov/30956204Diego Poddighe, Marine Van Hollebeke, Beatrix Clerckx...
https://pubmed.ncbi.nlm.nih.gov/39842329